欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
ES/V/0294/001
药品名称
Enrocat sabor 25 mg/ml
活性成分
enrofloxacin 25.0 mg/ml
剂型
Oral suspension
上市许可持有人
LIVISTO
参考成员国 - 产品名称
Spain (ES)
互认成员国 - 产品名称
Germany (DE)
Denmark (DK)
Iceland (IS)
Ireland (IE)
Austria (AT)
Enrocat flavour 25 mg/ml Suspension zum Eingeben für Katzen
Portugal (PT)
Italy (IT)
Greece (GR)
Finland (FI)
Poland (PL)
Latvia (LV)
Enrocat flavour 25 mg/ml suspensija iekšķīgai lietošanai kaķiem
Lithuania (LT)
Enrocat Flavour 25 mg/ml, geriamoji suspensija katėms
Estonia (EE)
Enrocat flavour
Hungary (HU)
Bulgaria (BG)
Czechia (CZ)
Enrocat flavour 25 mg/ml perorální suspenze pro kočky
Romania (RO)
Slovenia (SI)
United Kingdom (Northern Ireland) (XI)
许可日期
2019/12/18
最近更新日期
2021/05/28
药物ATC编码
QJ01MA90 enrofloxacin
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
Generic - art 13.2 Dir 2001/82/EC
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Product Information
|
1b_pil_d210 ENROCAT
Date of last change:2024/09/06
Final SPC
|
1b_spc_d210 ENROCAT
Date of last change:2024/09/06
PubAR
|
ENROCAT ES V 0294 001 DC final PuAR
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase